Pegylated human recombinant arginase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated human recombinant arginase, covering 2012-03-14 to 2012-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of Pegylated Human Recombinant Arginase for Liver Cancer [Phase 1]